Latest news
Loading news…
Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics.
Modifi Bio on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Modifi Bio was acquired by Merck in 2024 for $1.3B.
Total Funding
$6.7M
Funding Rounds
2
Last Funding
Acquisitions
0
Monthly Visits
Contacts
6
About Modifi Bio
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- New Haven, Connecticut, United States
Modifi Bio Funding Rounds
2 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Investor Names | Funding Stage | Org Industries | Org Hq City | Org Hq Country | Org Description | Org Number Of Employees | Org Website | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1–2 of 2Show
Page 1 / 1
6
professional contacts at Modifi Bio
Contact execs at Modifi Bio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about Modifi Bio
People who checked this page also checked these
Browse the full Acquirezy directory.